Clinical Trials Logo

Clinical Trial Summary

This study evaluates the efficacy of the HIFU for the treatment of benign thyroid nodules with the FastScan version using assessment of patient experience and adverse event reporting.


Clinical Trial Description

Echopulse is specially designed, manufactured and CE marked for treating benign thyroid nodules. HIFU is a completely alternative to surgery which utilizes high-energy ultrasound to deliver a large amount of sound energy to a focal point to rapidly induce tissue heating to 85-90°C.This initiates tissue coagulation followed by tissue necrosis ablating the targeted area. In a previous european feasibility study performed at 1 site (Bulgaria), 20 benign thyroid nodules were treated. The HIFU treatment was well tolerated and showed efficacy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02491502
Study type Interventional
Source Theraclion
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date July 2020

See also
  Status Clinical Trial Phase
Completed NCT02658552 - A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules N/A
Completed NCT03646383 - Study of the Feasibility of Radiofrequency Ablation of Benign Thyroid Nodules N/A
Active, not recruiting NCT04046354 - Microwave vs. Radiofrequency Ablation for Benign Thyroid Nodules: A Multicenter Randomized Controlled Trial Study N/A